Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
44 studies found for:    Open Studies | "Myositis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Myositis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
2 Not yet recruiting MYOPROSP - a Prospective Cohort Study in Myositis
Conditions: Myositis;   Idiopathic Inflammatory Myopathy
3 Recruiting Belimumab in Myositis
Condition: Myositis
Interventions: Drug: Belimumab;   Drug: Placebo
4 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
5 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
6 Not yet recruiting Study of Arimoclomol in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis
Interventions: Drug: Arimoclomol;   Other: Placebo
7 Recruiting Natalizumab in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis (IBM)
Intervention: Drug: Natalizumab
8 Recruiting Exercise in Sjogren, Myositis and Takayasu's Arteritis
Conditions: Primary Sjogren´s Syndrome;   Myositis
Intervention: Other: Exercise training
9 Unknown  Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation
Condition: Myositis
Intervention: Other: Physical Exercise
10 Recruiting Investigating Genes in Patients With Polymyositis and Dermatomyositis
Condition: Myositis
Intervention: Procedure: Venepuncture
11 Unknown  Diagnostic Accuracy of MR in Myositis
Conditions: Myositis;   Muscular Disorders, Atrophic
Intervention: Procedure: Magnetic Resonance Imaging
12 Recruiting Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis
Condition: Inclusion Body Myositis (IBM)
Interventions: Drug: Rapamycin;   Drug: Placebo
13 Unknown  A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
Condition: Idiopathic Inflammatory Myopathy
14 Unknown  Rituximab-induced Pulmonary Function Changes
Conditions: Rheumatoid Arthritis;   Inflammatory Myositis
Intervention: Other: Lung function measurement
15 Recruiting Environmental Risk Factors for the Anti-synthetase Syndrome
Condition: Myositis
16 Recruiting Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Conditions: Rheumatic Diseases;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Scleroderma;   Dermatomyositis;   Myositis
17 Recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
18 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
19 Not yet recruiting Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study
Condition: Sporadic Inclusion Body Myositis
20 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years